Alexandre Mouradian
Directeur Général chez eureKARE SA
Profil
Alexandre Mouradian is the founder of eureKARE SA, eureKING SA. He is currently the Chairman of Spinoza Foundation, Director of Stellate Therapeutics SAS, Director of Omne Possibile, and Director of Meletios Therapeutics SAS.
He completed his undergraduate degree at ESCP Europe Campus Paris.
Postes actifs de Alexandre Mouradian
Sociétés | Poste | Début |
---|---|---|
eureKARE SA
eureKARE SA BiotechnologyHealth Technology eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation. | Directeur Général | - |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Directeur/Membre du Conseil | - |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Fondateur | - |
Spinoza Foundation | Président | - |
Omne Possibile | Directeur/Membre du Conseil | - |
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Stellate Therapeutics, Inc. provides micro biome medicine. It also offers therapeutic products and associated diagnosis tools. The company was founded by Antoine Danchin and is headquartered in Paris, France. | Directeur/Membre du Conseil | - |
Formation de Alexandre Mouradian
ESCP Europe Campus Paris | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 6 |
---|---|
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Stellate Therapeutics, Inc. provides micro biome medicine. It also offers therapeutic products and associated diagnosis tools. The company was founded by Antoine Danchin and is headquartered in Paris, France. | Health Technology |
Omne Possibile | |
eureKARE SA
eureKARE SA BiotechnologyHealth Technology eureKARE SA is a start-up studio that specializes in synthetic biology. The private company is based in Senningerberg, Luxembourg. The Luxembourger company identifies opportunities and needs in areas including health, environment, sustainability, and biomanufacturing. The company's scientists use engineering techniques to modify and improve biological components like living cells. The company catalyzes their innovations into successful businesses with access to funding and the right resources. The company was founded by Alexandre Mouradian, Rodolphe Besserve, Bénédicte Garbil, and Alexandre Mouradian has been the CEO since incorporation. | Health Technology |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Meletios Therapeutics SAS is a French biotech company founded in 2020 by a team of high level scientists and experienced biotech managers. The company is based in Lyon, France. The company's aim is to fulfill the urgent and large unmet medical need for broad spectrum treatments against current and emerging viral infections. One of their first drug candidates has confirmed its broad-spectrum potential. Catherine Martre has been the CEO of the company since 2021. | Health Technology |
eureKING SA
eureKING SA Financial ConglomeratesFinance eureKING SA is a special purpose acquisition company, which engages in acquiring one or more companies or operating businesses, through a merger, capital stock exchange, share purchase, asset acquisition, reorganization or similar transaction. It focuses on the completion of an initial business combination with one or several target businesses and companies with principal operations in the biomanufacturing sector. The company was founded by Michael Kloss, Hubert Olivier, Gerard Le Fur, Christophe Jean, Alexandre Mouradian, and Rodolphe Besserve and is headquartered in Paris, France. | Finance |
Spinoza Foundation |